Change - Announcement of Appointment::Re-designation of Non-Executive Chairman to Executive Chairman
Issuer & Securities
Issuer/ Manager
TAT SENG PACKAGING GROUP LTD
Securities
TAT SENG PACKAGING GROUP LTD - SG1K31894969 - T12
Stapled Security
No
Announcement Details
Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
28-Jan-2022 19:16:38
Status
New
Announcement Sub Title
Re-designation of Non-Executive Chairman to Executive Chairman
Announcement Reference
SG220128OTHRNK96
Submitted By (Co./ Ind. Name)
Siau Kuei Lian
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Re-designation of Dr Goi Seng Hui from his current designation as Non-Executive Chairman to Executive Chairman
Additional Details
Date Of Appointment
01/02/2022
Name Of Person
Goi Seng Hui
Age
75
Country Of Principal Residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)
The Nominating Committee ("NC") has reviewed and considered the credentials and experience of Dr Goi. The NC has recommended and obtained the Board's concurrence to re-designate Dr Goi from his current designation as Non-Executive Chairman to Executive Chairman of the Company. Following his re-designation, Dr Goi will cease as a member of the Remuneration Committee and Nominating Committee.
Whether appointment is executive, and if so, the area of responsibility
Appointment is executive. The area of responsibility of the Executive Chairman are to provide leadership, stewardship and direction to the Board through making business recommendation and facilitating the overall strategic direction of the Company and deliberations of the Board.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Executive Chairman
Professional qualifications
Secondary level
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
Dr Goi is the Executive Chairman of Hanwell Holdings Limited, the substantial shareholder of the Company.
Conflict of interests (including any competing business)
Nil
Working experience and occupation(s) during the past 10 years
Executive Chairman of Hanwell Holdings Limited, Tee Yih Jia Food Manufacturing Private Limited and GSH Corporation Limited.
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
Dr Goi holds 409,700 shares in the capital of the Company.
Dr Goi also holds 164,802,904 shares in the capital of Hanwell Holdings Limited, the substantial shareholder of the Company.
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
Please refer to the attachment.
Present
Please refer to the attachment.
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
Yes
If Yes, Please provide details of prior experience
Dr Goi is the Executive Chairman of Hanwell Holdings Limited and GSH Corporation Limited, the Mainboard-listed companies in Singapore. Dr Goi also serves on the board of two other Mainboard-listed companies in Singapore, namely as Vice-Chairman of Envictus International Holdings Limited and JB Foods Limited. Dr Goi serves as non-executive and non-independent director of Tung Lok Group Restaurants (2000) Ltd, a company listed under the Catalist board.
Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable)
As disclosed above, Dr Goi has the relevant experience of several listed companies on the Exchange.
Attachments
Directorship_Current.pdf
Directorship_Past.pdf
Total size =842K
Related Announcements
Related Announcements